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The benefits of walnut (Juglans regia) consumption for metabolic health are known, but the molecular background underlying their
putative antioxidant and anti-inflammatory/immunomodulatory effects is underexplored. We assessed that walnut
supplementation (6 weeks) reverted unfavorable changes of the SIRT1/FoxO3a/MnSOD/catalase axis in the heart induced by
fructose-rich diet (FRD). Intriguingly, Nox4 was increased by both FRD and walnut supplementation. FRD increased the
cytosolic fraction and decreased the nuclear fraction of the uniquely elucidated ChREBP in the heart. The ChREBP nuclear
fraction was decreased in control rats subjected to walnuts. In addition, walnut consumption was associated with a reduction in
systolic BP in FRD and a decrease in fatty acid AA/EPA and AA/DHA ratios in plasma. In summary, the protective effect of
walnut supplementation was detected in male rats following the fructose-induced decrease in antioxidative/anti-inflammatory
capacity of cardiac tissue and increase in plasma predictors of low-grade inflammation. The current results provide a novel
insight into the relationship between nutrients, cellular energy homeostasis, and the modulators of inflammatory/immune
response in metabolic syndrome, emphasizing the heart and highlighting a track for translation into nutrition and dietary
therapeutic approaches against metabolic disease.
1. Introduction
An increase in total fructose consumption over the past
several decades has been correlated with metabolic syn-
drome (MetS) [1] and chronic inflammation [2]. The state
of chronic inflammation in MetS can be described as a tissue-
level stress response named “parainflammation” character-
ized by low-grade chronic activation of the immune system
[3]. Maladaptive immune and inflammatory responses lead
to systemic and cardiovascular insulin resistance [4], which
are linked with MetS, cardiovascular disease (CVD) [5],
and elevated oxidative stress [6, 7].
The role of nuts in the improvement of metabolic
health, weight management, and glucose/insulin homeosta-
sis markers and prevention of insulin resistance, hyperin-
sulinemia, dyslipidemia, and hypertension, the main
characteristics of MetS, was suggested but studies are quite
rare [8, 9]. In the protection of CVD, walnuts have the
leading role [10], with the highest amount of a polyunsat-
urated omega-3 fatty acids (n-3 PUFAs), which have
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antioxidant and anti-inflammatory/immunomodulatory
effects on the heart [11, 12]. They can be easily used in nutri-
tion and could be essential for use in low-marine food intake
countries. It has been shown that several different n-3 PUFA
derivatives, docosahexaenoic acid (DHA), and alpha-
linolenic acid (ALA) decrease ROS and NO production in
LPS-stimulated macrophages [13, 14]. On the other hand,
omega-6 fatty acids (arachidonic acid (AA)) are the precur-
sor of inflammatory agents such as PGE2, cytokines, and
interleukins and may have proinflammatory effects [15]. An
unbalanced omega-6/omega-3 ratio in favor of omega-6
PUFAs contributes to MetS-related diseases [16] and have
effects on immune cells [11]. An elevated AA/eicosapentae-
noic acid (EPA) ratio represents an inflammatory biomarker
in certain chronic diseases [17]; however, its capacity related
to MetS-related diseases and diverse nutritional treatments is
not fully understood.
Recent research suggests a strong link between the cel-
lular energy homeostasis and immune cell activation and
triggering of inflammation in response to cell and tissue
damage [18]. It is supported by recent findings of the
AMP-activated protein kinase (AMPK) role in inflamma-
tion and immunity [19], through AMPK repression of aer-
obic glycolysis and activation of mitochondrial oxidative
metabolism. This role of AMPK in the inhibition of oxidative
stress and inflammation seems to be closely related to a group
of fuel-sensing molecules, the sirtuins, both involved in met-
abolic syndrome-associated diseases [20]. AMPK and sirtuin
1 (SIRT1) activate each other, suggesting the existence of an
AMPK-SIRT1 cycle that links the cell’s energy and redox
states [20]. SIRT1 deacetylates the transcriptional regulator,
forkhead box O3 (FoxO3a), thereby promoting the initiation
of FoxO3a-dependent gene transcription [21] and upregula-
tion of the expression of genes involved in antioxidative
defence, such as mitochondrial manganese superoxide
dismutase (MnSOD) and catalase [22, 23]. Recent studies
have established a central role of SIRT1 in the relationship
of the immune response to metabolism that are closely
dependent on each other. SIRT1-mediated regulation of
cellular metabolism reprogramming [24] is closely linked to
a SIRT1 role in the appropriate dendritic cell function and
innate immunity. Namely, the absence of SIRT1 alters the
mitochondrial function and metabolic phenotype, resulting
in the induction of fatty acid synthesis and leading to dysreg-
ulation of innate and adaptive immunity [25]. Recent find-
ings [26] support a role of SIRT1 in the switch from early
to late inflammation. SIRT1 inactivates NADPH oxidase 4
(Nox4) in cardiomyocytes [27] and rat aorta [28], which is
of utmost importance for cardiomyocytes, as Nox4 is the
major source of mitochondrial oxidative stress [29]. SIRT1
could be repressed by direct binding of the carbohydrate
response element-binding protein (ChREBP) to its promoter,
in metabolic active tissues [30]. ChREBP regulates gene tran-
scription in glycolysis/fructolysis and de novo lipogenesis
[31], which suggests its important role in the pathogenesis
of metabolic diseases. Recent data [32] establish a critical role
for ChREBP in preventing macrophage inflammation and
apoptosis in atherosclerosis and demonstrate the importance
of immune metabolic flux in chronic inflammatory diseases.
Based on the pointed relationship between mitochondria
metabolism and inflammation/immunity and our previous
findings [33] regarding fructose effects on target molecules
in the heart, we hypothesized that walnut-enriched diet
should have the capacity to revert the fructose-rich diet-
induced changes in (1) metabolic stress axis mitochondrial
molecule SIRT1-FoxO3a-MnSOD/catalase in the rat heart
and Nox4 and ChREBP, as its unfavorable regulators, and
(2) harmful ratios of proinflammatory/anti-inflammatory
plasma PUFAs (omega-6/omega-3 fatty acid ratio), to
achieve cardioprotective effects. This work will give a new
insight into the relationship between nutrients, cellular
energy homeostasis, and the modulators of the inflammator-
y/immune response in MetS, emphasizing that the heart as
the molecular background of walnut supplementation in
metabolic disorders has not been fully addressed, yet.
2. Materials and Methods
2.1. Walnut Characterization. Walnuts (Juglans regia) used
in this study were purchased from a local market. A recent
study described the complete fatty acid, macronutrient, and
mineral composition of the walnuts [34]. In terms of fatty
acid content, the most abundant n-3 fatty acid in the walnuts
was ALA (C18:3 n-3, 11.2%), while linoleic acid (C18:2 n-6,
63.2%) was the most abundant n-6 fatty acid identified by
gas chromatography, similar to the data reported in the
European Food Information Resource [35].
2.2. Animal Model and Treatment. Twenty-one-day-old male
Wistar rats were randomly divided into two groups accord-
ing to diet regime—control group (C) (n = 18), with free
access to tap water and standard commercial rat chow, and
the fructose-fed group (F) (n = 18), with free access to the
same food and 10% (w/v) fructose solution instead of tap
water. Rats were housed in individual cages (3 rats per cage)
and maintained under standard temperature (22°C) and 12 h
light/dark cycles. This diet regime lasted for nine weeks. After
that period, half of the control (CW) and fructose-fed rats
received 2.4 g of dietary walnuts daily (FW), an amount
which corresponds to half of the kernel. To ensure the origi-
nal PUFA content in the walnuts, they were given to animals
as whole kernels ensuring that they were eaten by each ani-
mal. After six weeks of this diet regime, all rats were sacrificed
by decapitation and their hearts were removed, washed in
saline, and stored at −70°C until analysis, while blood sam-
ples were collected in EDTA-containing tubes for biochemi-
cal measurements. A total of 36 animals participated in the
experiment (9 animals per group), corresponding to the stan-
dards of statistics and ethics. Experimental protocols were
approved by the Ethical Committee of the “Vinča” Institute
of Nuclear Sciences for the Use of Laboratory Animals and
performed in accordance with the guidelines of Directive
2010/63/EU of the European Parliament.
2.3. Feeding Behavior, Metabolic Parameters, and Blood
Pressure of Experimental Animals. Food intake and liquid
intake were recorded daily, while body mass was recorded
weekly during the study period. Energy intake from the
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standard food, fructose solution, and walnuts was calculated
and expressed as daily intake in kJ per rat.
The heart mass was weighted after removing from the
body (absolute) and expressed relative to total body mass.
Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) as well as heart rate frequency (HRF) were measured
after dietary intervention in conscious rats by a noninvasive,
computerized tail-cuff method BP system (Rat Tail Cuff
Method Blood Pressure Systems (MRBP-R), IITC Life Sci-
ence Inc., USA) with external preheating [36]. Mean arterial
pressure (MAP), the average pressure in arteries during one
cardiac cycle, was calculated as DBP plus 1/3 (SBP minus
DBP). Pulse pressure (PP) was calculated as the difference
between SBP and DBP.
2.4. Fatty Acid Analysis in Total Plasma Lipids. Blood
samples were collected in EDTA tubes following overnight
fasting, and fatty acids were analyzed as described before
[37]. Briefly, plasma was separated by centrifugation
(1600 × g, 10min), aliquoted, and stored at −20°C until
analysis. Total plasma lipids were extracted by the method
of Folch et al. [38] using a chloroform-methanol mixture
(2 : 1) with 0.05% (w/v) butylated hydroxytoluene. Fatty
acids were esterified to methyl esters which were reconsti-
tuted in hexane and separated by gas chromatography on
the Shimadzu chromatograph (GC-2014, Kyoto, Japan)
equipped with a flame ionization detector and an RTX
2330-fused silica gel capillary column (60m × 0:25mm id
× 0:2 μm film thickness) (Restek Co., Bellefonte, PA, USA).
For the purposes of the current study, arachidonic acid
(AA) (20 : 4 n-6), eicosapentaenoic acid (EPA) (20 : 5 n-3),
and docosahexaenoic acid (DHA) (22 : 6 n-3) were identified
by comparing the peak retention times with a PUFA-2 stan-
dard mixture and Supelco 37 Component FAME Mix
(Supelco Inc., Bellefonte, PA, USA). The amounts of individ-
ual fatty acids in plasma were presented as a percentage of the
total identified fatty acids in the total lipid pool.
2.5. Cardiac Lysate Preparation. Cardiac tissue from three
animals of the same group was pooled to prepare lysate, cyto-
solic, and nuclear fractions. Frozen pooled hearts were
thawed and homogenized on ice with an Ultra-Turrax
Homogenizer in modified RIPA buffer (pH7.4) containing
50mM Tris–HCl, pH7.4, 150mM NaCl, 1% Triton X-100,
0.2% Na-deoxycholate, 0.2% SDS, 1mM EDTA, pH7.4, pro-
tease inhibitors (1mM PMSF, 10μg/mL leupeptin, and
10μg/mL aprotinin), and phosphatase inhibitors (1mM acti-
vated sodium orthovanadate and 10mM sodium fluoride).
The homogenates were centrifuged at 15000 × g for 30min
at 4°C. Supernatants were boiled in Laemmli sample buffer
and used as a cardiac cell lysate for Western blot analysis.
2.6. Preparation of Cytosolic and Nuclear Fractions. The rest
of the total pooled heart weight was homogenized on ice with
an Ultra-Turrax Homogenizer in homogenization TEMG
buffer (pH7.5) containing 50mM Tris–HCl, 1mM EDTA,
12mM monothioglycerol, 10% glycerol (v/v), protease, and
phosphatase inhibitors. The cell lysate was filtered through
gauze and centrifuged (1000 × g, 15min). Cytosolic proteins
were isolated from the original supernatant (Sn1), while
nuclear proteins were isolated from the original pellet. The
original supernatant (Sn1) was centrifuged at 12000 × g for
30min. The upper phase containing cytosolic proteins was
collected by centrifugation of the supernatant (Sn2) at
100000 × g for 1 h. The original pellet was washed twice in
TMG + 0:2% Triton X-100 buffer and once in TMG buffer,
pH7.5 (20mM Tris–HCl, 12mM monothioglycerol, and
10% glycerol (v/v)), followed by centrifugation (1000 × g,
15min) after each wash. The resulting pellet was resuspended
in TEMG + 0:5M KCL buffer and incubated on ice for 1 h
with frequent vortexing. The supernatant containing nuclear
proteins was collected by centrifugation of this resuspended
pellet (34 200 rpm, 1 h). Samples were boiled in Laemmli
sample buffer and used as a cardiac cytosolic and nuclear
fraction for Western blot analysis.
2.7. Western Blot Analysis. Cardiac proteins (50μg/lane)
were separated by electrophoresis on 10% SDS polyacryl-
amide gels and transferred to polyvinylidene fluoride
(PVDF) membranes. The uniformity of protein loading in
each lane was assessed by staining the membranes with
Ponceau S (Sigma-Aldrich, P3504), and this total protein
staining quantified by ImageJ software was used as a load-
ing control [39]. After destaining, membranes were blocked
with 5% (w/v) milk in TBST and incubated with primary
antibody for AMPK (sc-25792), SIRT1 (sc-74465), FoxO3a
(sc-11351), MnSOD (sc-30080), catalase (ab16731), Nox4
(ab133303), or ChREBP (NB400-135) overnight. Unbound
and nonspecifically bound antibodies were washed with
TBST, and membranes were incubated with horseradish
peroxidase- (HRP-) conjugated secondary anti-rabbit anti-
body (for AMPK, FoxO3a, MnSOD, catalase, and ChREBP
antibody) or anti-mouse antibody (for SIRT1 antibody)
(Santa Cruz Biotechnology) for 1.5 h at room temperature.
After washing, the proteins were visualized by the enhanced
chemiluminescence (ECL) method. The films were scanned,
and quantitative analyses based on densitometry of protein
bands on X-ray film were performed by ImageJ software
(NIH, USA). As AMPK, FoxO3a, and ChREBP shuttle
between the nucleus and the cytoplasm, protein levels of
their total forms were determined in the cytosolic and
nuclear fractions of cardiac tissue. The levels of SIRT1,
MnSOD, catalase, and Nox4 were determined in the cardiac
cell lysate. All Western blot experiment results were
expressed as the protein/total protein staining ratio. The
levels of proteins are presented as a fold of the appropriate
control value.
2.8. Statistical Analysis. Statistical analysis was performed
using Statistica software package. Data were expressed as
mean ± standard deviation (SD) for 9 animals per experi-
mental group (a total of 36 animals). The results were
analyzed using two-way analysis of variance (ANOVA)
(evaluating fructose and walnut factors, as well as mutual
interactions), followed by the Tukey’s post hoc test to
evaluate differences between groups. A value of p < 0:05
was considered as statistically significant.
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3. Results
3.1. Relative Heart Mass, Blood Pressure, and Heart Rate
Frequency in Experimental Treatments. We calculated the
energy intake in kJ/day/rat and expressed intake from each
source (chow food, fructose solution, and walnut) as a per-
centage of the total. Control animals had 100% chow energy
intake. The total energy intake of CW rats was the sum of
chow energy intake (90.66%) and walnut energy intake
(9.34%); while in the F group, it was the sum of the chow
energy intake (63.27%) and liquid energy intake (36.73%).
The FW group had a total energy intake from all three
sources: chow energy intake (59.13%), liquid energy intake
(33.43%), and walnut energy intake (7.44%). There was no
significant difference in liquid energy intake in the F and
FW groups yet; as previously published in the current animal
model, the significant main effect of fructose (p < 0:001) and
walnut supplementation (p < 0:01) on total energy intake was
detected [40].
We detected significant main effects of walnut supple-
mentation on relative heart mass (two-way ANOVA, p <
0:01), but post hoc comparisons showed a significant differ-
ence only between control animals and combined fructose
and walnut treatment (p = 0:04) (Table 1). Total body mass
at the end of the study was affected by both factors, FRD
(p < 0:01) and walnut supplementation (p < 0:001).
We also demonstrated the significant main effects of
walnut supplementation and fructose × walnut interaction
(p < 0:01, partial eta-squared 0.45, observed power 0.93
for alpha = 0:05) on systolic blood pressure, while these
factors did not show any significant effect on diastolic
blood pressure (Table 1). Walnut supplementation gained
the significant main effect on the heart rate frequency
(p < 0:01) (Table 1). Post hoc test revealed no effect of
walnut-enriched diet on blood pressure and heart rate fre-
quency of control rats; but in fructose-fed rats, walnut
supplementation was associated with a significant reduc-
tion in systolic blood pressure (F vs FW, p < 0:01, and C
vs FW, p < 0:05) and showed trend toward a decrease in
heart rate frequency (F vs FW, p = 0:08). However, fruc-
tose and walnut consumption and their interaction did
not have a significant effect on either MAP or PP.
3.2. Effects of Fructose-Rich Diet and Walnut Supplementation
on AA/EPA and AA/DHA in Total Plasma Lipids. Our results
showed that the intake of walnuts reversed the fructose-
induced increase in AA/EPA (p for interaction<0.001, partial
eta-squared 0.39, and observed power 0.99 for alpha = 0:05).
On the other hand, regardless of the metabolic burden associ-
ated with fructose intake, walnut supplementation decreased
AA/DHA levels (p = 0:013, Table 2).
3.3. Effects of Fructose-Rich Diet and Walnut
Supplementation on the Protein Content of AMPK-SIRT1-
FoxO3a-MnSOD/Catalase, ChREBP, and Nox4 in the Heart
of Male Rats. Our results did not show any significant effect
of fructose/walnut supplementation or fructose × walnut
interaction on the cytosolic or nuclear AMPK protein level
in the rat heart (Figures 1(a) and 1(b)).
The results showed the significant main effects of fructose
(p < 0:05) and fructose × walnut interaction (p < 0:001,
partial eta-squared 0.30, and observed power 0.98 for alpha
= 0:05) on the SIRT1 protein level (Figure 2). FRD signifi-
cantly decreased the SIRT1 protein level in rat hearts com-
pared to control animals (C vs F, p < 0:001), while the
walnut supplementation of fructose-fed animals elevated its
level compared to rats fed only fructose (F vs FW, p < 0:01).
The results demonstrated a significant effect of fructose
× walnut interaction on the cytosolic FoxO3a protein level
(p < 0:05, partial eta-squared 0.10, and observed power 0.54
for alpha = 0:05) and significant main effects of fructose
(p < 0:05) and walnut supplementation (p < 0:001) on the
nuclear FoxO3a protein level (Figures 3(a) and 3(b)). FRD
significantly increased the cytosolic FoxO3a protein level (C
vs F, p < 0:05), while walnut supplementation elevated the
nuclear FoxO3a protein level in the hearts of both, control
(C vs CW, p < 0:001) and fructose-fed rats (F vs FW, p <
0:001, and C vs FW, p < 0:001, respectively).
Table 1: Effects of fructose-rich diet and walnut supplementation on total body mass, relative heart mass, and blood pressure in experimental
rats.
C CW F FW
Two-way ANOVA
W F F ×W
Total body mass (g) 463:22 ± 34:3 513:33 ± 36:54∗ 485:44 ± 30:78 554:44 ± 33:22∗∗∗,$$$ <0.001 <0.01 NS
Heart mass/total body mass (×100) 0:25 ± 0:02 0:23 ± 0:02 0:24 ± 0:01 0:22 ± 0:03∗ <0.01 NS NS
SBP (mm·hg) 147:4 ± 3:36 149:8 ± 3:49 150:8 ± 5:54 138:8 ± 4:97∗,$$,## <0.05 NS <0.01
DBP (mm·hg) 84:6 ± 6:8 91 ± 9:49 88:8 ± 13:81 84:6 ± 5:03 NS NS NS
HRF (beats/min) 359:6 ± 29:31 323:2 ± 29:52 390:4 ± 42:17 336:6 ± 27:02 <0.01 NS NS
MAP (mm·hg) 103:17 ± 6:3 107:06 ± 10:21 106:06 ± 12:39 107:17 ± 9:33 NS NS NS
PP (mm·hg) 62:5 ± 9:89 58:17 ± 10:15 62:67 ± 10:98 54:50 ± 15:67 NS NS NS
Data are presented asmean ± SD for 9 animals per group. A value of p < 0:05 was considered as statistically significant. C: animals on standard laboratory chow;
CW: animals on standard laboratory chow and walnut supplementation; F: animals fed a fructose-rich diet; FW: fructose-fed animals on walnut
supplementation; SBP: systolic blood pressure; DBP: diastolic blood pressure; HRF: heart rate frequency; MAP: mean arterial pressure; NS: not significant.
Significantly different from ∗control, #walnuts, and $fructose. Significance is ∗p < 0:05, ##$$p < 0:01, and ∗∗∗$$$p < 0:001.
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Significant main effects of fructose and walnut supple-
mentation on the MnSOD (p < 0:001 and p < 0:01, respec-
tively) and catalase (p < 0:001 and p < 0:001, respectively)
protein levels were detected (Figures 4(a) and 4(b)). FRD
decreased the MnSOD and catalase protein levels (C vs F, p
< 0:01, for both), while walnut supplementation reverted
these changes (F vs FW, p < 0:05 and p < 0:01, respectively).
Walnut-enriched diet significantly increased the catalase
level even in control animals (C vs CW, p < 0:05).
The significant main effects of fructose (p < 0:001) and
walnut supplementation (p < 0:01) as well as a significant
effect of fructose × walnut interaction (p < 0:05, partial eta-
squared 0.15, and observed power 0.72 for alpha = 0:05) on
the Nox4 protein level were detected (Figure 5). Post hoc
analyses revealed a significant increase in Nox4 protein
expression after both FRD (C vs F, p < 0:001) and walnut
supplementation (C vs CW, p < 0:01, and C vs FW, p <
0:001) compared to the control group.
A significant main effect of fructose on the cytosolic
ChREBP protein level (p < 0:01) as well as a significant
effect of fructose × walnut interaction on the nuclear
ChREBP protein level (p < 0:001, partial eta-squared 0.25,
and observed power 0.99 for alpha = 0:05) was demon-
strated (Figures 6(a) and 6(b)). Post hoc analyses revealed
that FRD increased the ChREBP protein level in the
Table 2: Effects of fructose-rich diet and walnut supplementation on the total plasma AA/EPA and AA/DHA ratio in experimental rats.
C CW F FW
Two-way ANOVA
F W F ×W
AA/EPA 116 ± 58 87:09 ± 20:31 204:50 ± 46:87 58:92 ± 17:09 0.032 0.000 0.000
AA/DHA 15:17 ± 7:35 8:28 ± 2:61 12:36 ± 3:80 11:17 ± 2:35 0.977 0.013 0.071
Data are presented asmean ± SD for 9 animals per group. A value of p < 0:05 was considered as statistically significant. C: animals on standard laboratory chow;
F: animals fed a fructose-rich diet; CW: animals on standard laboratory chow and walnut supplementation; FW: fructose-fed animals on walnut
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Figure 1: Effects of fructose-rich diet and supplementation with walnuts on the (a) cytosolic and (b) nuclear AMPK protein levels in the heart
of experimental rats. Values are means with standard deviations represented by vertical bars for 9 animals per group. C: animals on standard
laboratory chow; F: animals fed a fructose-rich diet; CW: animals on standard laboratory chow and walnut supplementation; FW: fructose-fed
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Figure 2: Effects of fructose-rich diet and supplementation with
walnuts on the SIRT1 protein level in the heart of experimental
rats. Values are means with standard deviations represented by
vertical bars for 9 animals per group. C: animals on standard
laboratory chow; F: animals fed a fructose-rich diet; W: animals
fed a dietary walnut; CW: animals on standard laboratory chow
and walnut supplementation; FW: fructose-fed animals on walnut
supplementation; ∗∗p < 0:01; ∗∗∗p < 0:001.
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cytosolic fraction (C vs F, p < 0:01) and decreased its level
in the nuclear fraction compared to the control group (C
vs F, p < 0:01). Walnut consumption significantly
decreased the nuclear ChREBP protein level in control rats
(C vs CW, p < 0:001) and showed a trend toward an
increase in the cytosolic ChREBP protein level of control
rats (C vs CW, p = 0:07). In the cytosolic fraction, walnut
consumption significantly increased the ChREBP protein
level in fructose-fed rats compared to the control group
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Figure 3: Effects of fructose-rich diet and walnuts on the (a) cytosolic and (b) nuclear FoxO3a protein levels in the heart of experimental rats.
Values are means with standard deviations represented by vertical bars for 9 animals per group. C: animals on standard laboratory chow; F:
animals fed a fructose-rich diet; CW: animals on standard laboratory chow and walnut supplementation; FW: fructose-fed animals on walnut
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Figure 4: Effects of fructose-rich diet and walnuts on the (a) MnSOD and (b) catalase protein levels in the heart of experimental rats. Values
are means with standard deviations represented by vertical bars for 9 animals per group. C: animals on standard laboratory chow; F: animals
fed a fructose-rich diet; CW: animals on standard laboratory chow and walnut supplementation; FW: fructose-fed animals on walnut
supplementation; ∗p < 0:05; ∗∗p < 0:01.
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4. Discussion
Among other nuts, walnuts could be promising for use in
dietary supplementation as they contain high levels of n-3
PUFAs, dietary fiber, antioxidants, and phytosterols [10,
41]. Our study suggests a beneficial role of walnuts in
the improvement of the metabolic status that is mainly
impaired by high fructose intake, a common component
of the modern lifestyle. In addition, we demonstrated an
increased omega-6/omega-3 ratio in FRD rats, which has
been suggested to be highly prothrombotic and proinflam-
matory and to contribute to the prevalence of atherosclerosis
and MetS-related diseases [16, 42]. The tissue-specific
omega-6/omega-3 decrease after walnut consumption in
high-fructose-fed Wistar rats was recently demonstrated
[37]. An increase in the AA/EPA ratio as a result of fructose
feeding in our study could be deleterious for the heart; previ-
ously, it has been suggested that higher levels of the AA/EPA
ratio are associated with a greater risk for CVD and has been
proposed as a biochemical marker of CVD events [16, 42].
We demonstrated a decrease in the AA/EPA and AA/DHA
ratio in plasma as a result of walnut consumption and
walnut × fructose interaction, which confirms that walnut
consumption could be beneficial in dietary regime especially
in MetS and in the prevention of CVD associated with MetS.
The additional beneficial effect of walnut consumption in our
study was the reduction of systolic BP in FRD rats, another
risk factor for CVD. In the literature, the effect of walnuts
or other nuts on BP was inconsistent yet but our result is in
line with studies that have found a reduction in BP [9, 43].
Effects of walnut consumption on BP lowering in FRD rats
may be related to the rich cation content, such as magnesium
and potassium [44] and high content of ALA [10], which
induces coronary VSMC relaxation [45]. The observed effect
of walnut consumption on BP could be in association with its
beneficial effect on the vascular tone, through the ATP-
sensitive potassium channel, recently presented in the same
model of FRD rats [40].
The main results of our study about the beneficial effects
of walnuts on the antioxidant AMPK-SIRT1-FoxO3a-
MnSOD/catalase axis in the heart of fructose-fed male rats
are in line with previous evidence that n-3 PUFAs induce
significant cardiovascular benefits, which appear to be
achieved via its antioxidant and anti-inflammatory/immuno-
modulatory effects on the heart [11, 12]. The decrease of the
omega-6/omega-3 fatty acid ratio, which is in our study
related to walnut consumption, has been previously associ-
ated with a decrease of circulating inflammatory markers
[46, 47]. Several recent studies have connected inflammation
with fatty acids as important providers of nutritional needs of
immune cells after sensing metabolic stress [48]. Two nutri-
ent sensors, AMPK and SIRT1, interact to inhibit oxidative
stress and macrophage inflammation, which appear to be
involved in the pathogenesis of MetS [20]. Decreased
nuclear SIRT1 levels/activity increases NF-κB activity and
amplifies proinflammatory gene expression during chronic
inflammation [49]. On the other hand, activation of SIRT1
by polyphenol fisetin [50] or by n-3 PUFA [51] was
observed to be anti-inflammatory through inhibition of
downstream expression of cytokines, chemokines, prosta-
glandins, and MMP-s. This guided us to investigate SIRT1
and AMPK in the heart of FRD rats, as well as the potential of
walnuts to rebalance sirtuins as molecules that integrate
metabolism, bioenergetics, and immunity during inflamma-
tion in MetS. Previously, we have detected that fructose could
contribute to inflammation through the changes of MMP-9
expression that could be mediated via the NF-κB pathway
in the heart [2]. In addition, we showed that estrogen replace-
ment exerted beneficial effects on the AMPK-SIRT1-
FoxO3a-MnSOD/catalase axis in the heart of FRD rats,
which has been compromised by fructose overload [33].
The effects of walnut supplementation on this axis and
related molecules, Nox4 and ChREBP, in the heart of FRD
rats have not been previously determined. We hypothesized
that reduced oxidative stress in the heart, as a result of walnut
supplementation, could be also mediated by suppression of
ROS production by Nox4. It has been demonstrated that n-
3 PUFA could disrupt Toll-like receptor 4- (TLR4-) induced
activation of Nox [52] and inhibit ROS-dependent activation
of the proinflammatory transcription factor NF-κB in endo-
thelial cells [53]. It was documented that a diet enriched with
60% fructose increased the levels of Nox4 mRNA in the rat
heart and aorta [6]. In the current study, a diet enriched with
10% fructose increased the protein level of Nox4 in the rat
heart. As previously denoted, Nox-mediated ROS production
has a central role in vascular inflammatory responses during
nutritional excess [54]. Vascular Nox production could be
additionally enhanced by Ang II [55], which is the main























Figure 5: Effects of fructose-rich diet and walnut supplementation
on the Nox4 protein level in the heart of experimental rats. Values
are means with standard deviations represented by vertical bars
for 9 animals per group. C: animals on standard laboratory chow;
F: animals fed a fructose-rich diet; CW: animals on standard
laboratory chow and walnut supplementation; FW: fructose-fed
animals on walnut supplementation; ∗∗p < 0:01; ∗∗∗p < 0:001.
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RAS in the heart/aorta of a fructose-fed rat model [56].
Activated NADPH oxidase leads to the generation of
ROS, which activate NF-κB to increase the transcription
of cytokines (TNF and IL-6). The binding of these cytokines
to their sarcolemmal receptors induce serine kinases that
phosphorylate IRS-1 and inhibit cardiac insulin signaling,
providing a novel interaction path between Ang II and insu-
lin signaling [57]. In the present study, elevated Nox4 protein
levels induced by FRD contribute to inflammation in the
heart, possibly through Ang II- and ROS-dependent mecha-
nisms. However, recent data also suggested a possible ather-
oprotective role of Nox4 [58, 59], as well as its role in
maintaining the cardiac energetic status [60]. In line with
this, we could suggest that increased Nox4 protein levels in
control animals after walnut supplementation, detected in
our study, indicate its possible role in cardiovascular homeo-
stasis and adaptation to chronic inflammatory stress. Even
so, this should be further investigated.
While both FRD and walnut supplementation did not
affect AMPK, they did significantly alter the SIRT1 protein
level, indicating the possibility that SIRT1 expression in
the heart is not regulated via AMPK, at least in current
experimental conditions, which is in agreement with our
previous study [33] and recent results in the aorta in the
same FRD model [40]. Herein, FRD decreased the SIRT1
protein level in the rat heart, in line with the findings that
MetS, obesity, and chronic inflammation have been associ-
ated with reduced levels of SIRT1 [61]. SIRT1-deficient
ob/ob mice show exaggerated microvascular inflammation
in comparison with lean mice [62]. In addition, SIRT1
deletion in myeloid cells increased the infiltration of M1
macrophages and decreased M2 macrophages in adipose
tissue in mice on high-fat diets, resulting in insulin resis-
tance [63] that is present in our FRD model. The studies
of Yoshizaki et al. directly linked the anti-inflammatory
effects of SIRT1 in adipocytes and macrophages with
improved insulin sensitivity [64]. SIRT1 has been located in
the nuclei of a significant fraction of cardiomyocytes [65]
and could yield protection of cardiomyocytes. In alignment
with our hypothesis, walnut supplementation restored the
SIRT1 protein level in the FRD rat heart, indicating pro-
tection of the heart and a probable decrease of inflamma-
tion. The pluripotent regulatory role of sirtuins, which we
previously discussed, leads to their recognition as new
therapeutic targets. Thus, the determined effect of walnuts
on SIRT1 represents the basis for further investigation of
nutritional treatments regarding the metabolic state and
inflammatory/immunomodulatory processes in the heart.
The downstream effects of SIRT1 include promotion of
FoxO3a dephosphorylation and consequent initiation of
FoxO3a-dependent gene transcription [28]. Our results
suggest that a decrease in SIRT1 by FRD might underline
the increased FoxO3a phosphorylation and downregulation
of dependent genes. As FoxO3a regulates gene expression
of MnSOD [22] and catalase [23], their decreased protein
content in fructose-fed rats in the current study might be
related to increased cytosolic FoxO3a in FRD. Importantly,
our study revealed a significant increase in the nuclear
protein level of FoxO3a following walnut supplementation,
and consequently, we detected an increase in the MnSOD
and catalase protein content in walnut-enriched diet groups.
Fructose activates ChREBP, which could repress SIRT1
expression in metabolic-active tissues [30], but data about
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Figure 6: Effects of fructose-rich diet and walnut supplementation on the (a) cytosolic and (b) nuclear ChREBP protein levels in the heart of
experimental rats. Values are means with standard deviations represented by vertical bars for 9 animals per each group. C: animals on
standard laboratory chow; F: animals fed a fructose-rich diet; CW: animals on standard laboratory chow and walnut supplementation;
FW: fructose-fed animals on walnut supplementation; ∗∗p < 0:01; ∗∗∗p < 0:001.
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activity was markedly higher in rats fed with high fructose
compared with isocaloric high-glucose diets [66]. During
fasting, the nuclear import and transactivity of ChREBP were
inactivated [67] while these processes are activated by the
products of carbohydrate metabolism [68]. In our study,
however, FRD significantly increased the cytosolic and
decreased nuclear ChREBP protein levels in the heart. The
lack of studies dealing with ChREBP in the heart and the
complexity of tissue-specific expression suggest probable dif-
ferential expression of ChREBP in the heart compared to
metabolic active tissues [31, 69]. It is feasible that SIRT1
expression in the heart is not regulated via ChREBP and that
ChREBP is important to regulate gene transcription in glyco-
lysis/fructolysis in tissues that preferentially oxidize carbohy-
drates, to provide ATP for energy-expensive metabolic
processes [70]. Fatty acid oxidation provides 60–70% of the
energy requirements in the heart [71], but fructose can also
be used as an energy substrate in the heart, considering that
cardiomyocytes express the fructose-specific GLUT5 trans-
porter [72]. Our results suggest that ChREBP is also more
prevalent in the cytosol after walnut supplementation of
fructose-fed animals, indicating the suppression of ChREBP
activity in the heart of walnut-fed rats. A decreased level of
nuclear localization of ChREBP in the heart after walnut sup-
plementation, similar to the previously shown in the liver on
high-fat diet [67], could be due to elevated amounts of fatty
acids in the heart. Fatty acid-rich diets have been shown to
suppress ChREBP expression by accelerating ChREBP
mRNA decay [67, 73] and inhibit the nuclear localization of
ChREBP [73]. Decreased DNA-binding activity of ChREBP
has been observed in rats fed a high-fat diet, compared to a
high-carbohydrate diet, which also implicates ChREBP in
the mechanism of fatty acid inhibition of glycolysis and lipo-
genesis [67, 69]. However, further results on the ChREBP in
the heart should be provided to bring us closer to understand
its role upon nutritional treatment.
5. Conclusions
The current study has confirmed the benefits of walnut
consumption and suggested the mechanisms underlying
their cardioprotective effects, emphasizing the role of
SIRT-1 as the nutritional sensor that transmits molecular
signals responsible for the metabolic state and inflamma-
tory/immunomodulatory processes in the heart. The
SIRT1-FoxO3a-MnSOD/catalase axis, compromised by fruc-
tose overload, was balanced upon walnut treatment. The
anti-inflammatory effect of walnut fatty acids, expressed in
the form of a decreased AA/EPA and AA/DHA ratio, is likely
mediated through negative regulation of NF-κB signaling
and downstream cytokine expression, which should be inves-
tigated in the future study. Intriguing results of a decrease in
nuclear ChREBP in the heart upon walnut supplementation,
resembling changes in the metabolic tissue on high-fat diet,
should be further deepened as the available data about this
molecule in the heart are scarce. Nevertheless, this study
provides novel data regarding the molecular background
of anti-inflammatory and antioxidative effects of walnuts
in the heart, which may be translated into modulation of
nutrition and dietary therapeutic approaches against meta-
bolic disease.
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